Cargando…
MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in Colorectal Cancer Organoids
Tumor-specific MHC class II (tsMHC-II) expression impacts tumor microenvironmental immunity. tsMHC-II positive cancer cells may act as surrogate antigen-presenting cells and targets for CD4(+) T cell–mediated lysis. In colorectal cancer, tsMHC-II negativity is common, in cell lines due to CIITA prom...
Autores principales: | Pickles, Oliver J., Wanigasooriya, Kasun, Ptasinska, Anetta, Patel, Akshay J., Robbins, Helen L., Bryer, Claire, Whalley, Celina M., Tee, Louise, Lal, Neeraj, Pinna, Claudia M.A., Elzefzafy, Nahla, Taniere, Philippe, Beggs, Andrew D., Middleton, Gary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411481/ https://www.ncbi.nlm.nih.gov/pubmed/37565053 http://dx.doi.org/10.1158/2767-9764.CRC-23-0091 |
Ejemplares similares
-
Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer
por: Wanigasooriya, Kasun, et al.
Publicado: (2022) -
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity
por: Bosworth, Andrew, et al.
Publicado: (2020) -
Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
por: Wanigasooriya, Kasun, et al.
Publicado: (2020) -
The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden
por: Hallam, Sally, et al.
Publicado: (2020) -
Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer
por: Pickles, Oliver J., et al.
Publicado: (2020)